Genital Diseases, Female  >>  Proellex (telapristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Proellex (telapristone) / AbbVie
NCT00556075: Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Terminated
2
67
US
Proellex 25 mg, Placebo, Proellex 50 mg
Repros Therapeutics Inc.
Endometriosis
05/09
07/09
NCT00958412: Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study

Terminated
2
18
US
Proellex®, CDB-4124
Repros Therapeutics Inc.
Endometriosis
08/09
08/09
NCT01961908: Open-Label Extension Study to ZPE-202

Withdrawn
2
0
US
Proellex, telepristone acetate
Repros Therapeutics Inc.
Endometriosis
12/14
12/14

Download Options